ea0030s19 | Keynote Lecture | BSPED2012
Pickup John
The benefits of continuous subcutaneous insulin infusion (CSII, insulin pump therapy) in type 1 diabetes, compared to multiple dose insulin injections (MDI), include a reduction in HbA1c, the frequency of all grades of hypoglycaemia, insulin dosage and glycaemic variability, and improved patient satisfaction with therapy and improved quality of life. The evidence base for this is now well established from meta-analyses of randomised controlled trials (RCTs) and from clinical o...